Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Levi

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
British Journal of Haematology|December 18, 2012
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patientsTommaso Za, Valerio De Stefano, Elena Rossi, et al.
Blood|September 3, 2010
Efficacy and safety of once-weekly bortezomib in multiple myeloma patientsSara Bringhen, Alessandra Larocca, Davide Rossi, et al.
Blood|December 8, 2009
Melphalan 200 mg/m(2) versus melphalan 100 mg/m(2) in newly diagnosed myeloma patients: a prospective, multicenter phase 3 studyAntonio Palumbo, Sara Bringhen, Benedetto Bruno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2014
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survivalAntonio Palumbo, Sara Bringhen, Alessandra Larocca, et al.
Dermatology Practical & Conceptual|March 30, 2026
CORONATE: A Novel Questionnaire to Assess the Long-Term Impact of Psoriasis on Patients' LivesStefano Piaserico, Francesca Sampogna, Martina Accorinti, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
British Journal of Haematology|December 18, 2012
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patientsTommaso Za, Valerio De Stefano, Elena Rossi, et al.
Blood|September 3, 2010
Efficacy and safety of once-weekly bortezomib in multiple myeloma patientsSara Bringhen, Alessandra Larocca, Davide Rossi, et al.
Blood|December 8, 2009
Melphalan 200 mg/m(2) versus melphalan 100 mg/m(2) in newly diagnosed myeloma patients: a prospective, multicenter phase 3 studyAntonio Palumbo, Sara Bringhen, Benedetto Bruno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2014
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survivalAntonio Palumbo, Sara Bringhen, Alessandra Larocca, et al.
Dermatology Practical & Conceptual|March 30, 2026
CORONATE: A Novel Questionnaire to Assess the Long-Term Impact of Psoriasis on Patients' LivesStefano Piaserico, Francesca Sampogna, Martina Accorinti, et al.
Pageof 4